De Novo Germline Variants and Generalized Acanthosis Nigricans
JAMA Dermatology 10.1001/jamadermatol.2025.5414January 14, 2026 at 11:00 AM EST
Is early-onset severe generalized acanthosis nigricans (AN) associated with an increased risk of systemic disease?In this case series study of 3 individuals with AN, using whole-exome sequencing (WES), recurrent de novo epidermal growth factor receptor () variants were identified in 2 patients with acquired, severe generalized AN that was associated with pulmonary nodules and progressive pulmonary disease for 1 patient. Skin and pulmonary disease improved with inhibitor treatment.The study results suggest that variants are associated with severe generalized AN and pulmonary disease that can be treated with inhibitors.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.